PL2379085T3 - Preparat farmaceutyczny zawierający supernatant z hodowli komórek jednojądrzastych - Google Patents

Preparat farmaceutyczny zawierający supernatant z hodowli komórek jednojądrzastych

Info

Publication number
PL2379085T3
PL2379085T3 PL09795769T PL09795769T PL2379085T3 PL 2379085 T3 PL2379085 T3 PL 2379085T3 PL 09795769 T PL09795769 T PL 09795769T PL 09795769 T PL09795769 T PL 09795769T PL 2379085 T3 PL2379085 T3 PL 2379085T3
Authority
PL
Poland
Prior art keywords
cell culture
pharmaceutical preparation
culture supernatant
preparation containing
mononuclear cell
Prior art date
Application number
PL09795769T
Other languages
English (en)
Inventor
Hendrik Jan Ankersmit
Original Assignee
Aposcience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aposcience Ag filed Critical Aposcience Ag
Publication of PL2379085T3 publication Critical patent/PL2379085T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09795769T 2008-12-18 2009-12-18 Preparat farmaceutyczny zawierający supernatant z hodowli komórek jednojądrzastych PL2379085T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08450198A EP2198873A1 (en) 2008-12-18 2008-12-18 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
PCT/EP2009/067534 WO2010079086A1 (en) 2008-12-18 2009-12-18 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
EP09795769.0A EP2379085B1 (en) 2008-12-18 2009-12-18 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture

Publications (1)

Publication Number Publication Date
PL2379085T3 true PL2379085T3 (pl) 2014-01-31

Family

ID=40478351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09795769T PL2379085T3 (pl) 2008-12-18 2009-12-18 Preparat farmaceutyczny zawierający supernatant z hodowli komórek jednojądrzastych

Country Status (12)

Country Link
US (1) US11235003B2 (pl)
EP (2) EP2198873A1 (pl)
JP (1) JP5869343B2 (pl)
CN (1) CN102256608B (pl)
AU (1) AU2009336668B2 (pl)
CA (1) CA2746862C (pl)
ES (1) ES2429518T3 (pl)
NZ (1) NZ593364A (pl)
PL (1) PL2379085T3 (pl)
RU (1) RU2533253C2 (pl)
WO (1) WO2010079086A1 (pl)
ZA (1) ZA201104349B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2867976A1 (en) * 2009-03-05 2010-09-10 Macrocure, Ltd. Activated leukocyte composition
WO2015046627A1 (ja) * 2013-09-30 2015-04-02 国立大学法人九州大学 創傷治癒促進剤
WO2017209480A2 (ko) * 2016-05-30 2017-12-07 주식회사 젬백스앤카엘 말초혈액 유래 단핵세포 및 혈소판 농축 혈장을 포함하는 피부재생 및 노화방지용 조성물 및 이를 이용한 피부 재생 방법
TWI732787B (zh) * 2016-10-04 2021-07-11 訊聯生物科技股份有限公司 經溫度調控刺激之多胜肽組成物的製備方法
EP3305306A1 (en) * 2016-10-04 2018-04-11 Dr. Sarah Prinzessin von Isenburg Compositions comprising adjustable concentrations of growth factors derived from blood serum and clot hypoxia-conditioned medium and methods of their production
CN106344612A (zh) * 2016-11-11 2017-01-25 上海鸣大生物科技有限公司 一种用于治疗自身免疫性皮肤病的外用药物及其制备方法和应用
CN106389467A (zh) * 2016-11-11 2017-02-15 上海鸣大生物科技有限公司 一种用于治疗皮炎和湿疹类皮肤病的外用药物及其制备方法和应用
CN106265737A (zh) * 2016-11-11 2017-01-04 上海鸣大生物科技有限公司 一种用于治疗皮肤附属器及瘙痒性皮肤病的外用药物及其制备方法和应用
CN106265738A (zh) * 2016-11-11 2017-01-04 上海鸣大生物科技有限公司 一种用于治疗病原体感染性皮肤病的外用药物及其制备方法和应用
CN106491645A (zh) * 2016-11-11 2017-03-15 上海鸣大生物科技有限公司 一种用于治疗物理性皮肤病及动物性皮肤病的外用药物及其制备方法和应用
CN106344613A (zh) * 2016-11-11 2017-01-25 上海鸣大生物科技有限公司 一种nk细胞原液在制备治疗皮肤病药物中的应用
KR102311057B1 (ko) * 2017-12-14 2021-10-08 (주)녹십자웰빙 아토피성 피부염, 탈모, 상처 또는 피부 주름의 개선용 화장료 조성물 및 약학 조성물
KR102014467B1 (ko) * 2017-12-14 2019-08-26 (주)녹십자웰빙 아토피성 피부염, 탈모, 상처 또는 피부 주름의 개선용 화장료 조성물 및 약학 조성물
CN108042567A (zh) * 2017-12-15 2018-05-18 广州金塞迩中西医结合医院有限公司 用于软骨修复的生物组合制剂及其应用
EP3502692A1 (en) * 2017-12-20 2019-06-26 Aposcience AG Potency assay for secretomes
KR102216710B1 (ko) * 2019-03-27 2021-02-17 신지섭 Nk세포배양배지용 첨가조성물, 상기 첨가조성물을 이용한 nk세포배양방법 및 상기 배양방법으로 얻어진 피부트러블개선용 화장료조성물
EP3962493A2 (en) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor
EP3842064A1 (en) * 2019-12-23 2021-06-30 Aposcience AG Composition for treating or preventing an allergy or allergic reaction
CN111334472A (zh) * 2020-03-27 2020-06-26 郑州鲲鹏健康科技有限公司 Pbmc体外3d胶原蛋白水凝胶培养基及其制备方法
CN111773249A (zh) * 2020-07-31 2020-10-16 上海鸣大生物科技有限公司 一种组合物及其制备方法
WO2022140457A1 (en) 2020-12-21 2022-06-30 Flagship Pioneering Innovations V, Inc. Use of cell turnover factors for increasing tissue regeneration
EP4074320A1 (en) 2021-04-13 2022-10-19 Aposcience AG Treatment of skin scars
EP4197547A1 (en) * 2021-12-20 2023-06-21 Aposcience AG Composition for treating or preventing vasculitis and diseases associated with vasculitis
EP4628570A1 (en) 2024-04-03 2025-10-08 Aposcience AG Method for cultivating mammalian cells
EP4706667A1 (en) 2024-09-05 2026-03-11 Aposcience AG Pharmaceutical composition for treating wounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066370A1 (en) * 1998-03-30 2001-01-10 I.D.M. Immuno-Designed Molecules Stimulated monocyte derived cells, their preparation and uses
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US20070110737A1 (en) * 2003-12-29 2007-05-17 Allan Mishra Compositions and method for decreasing the appearance of skin wrinkles
CA2559110A1 (en) * 2004-03-09 2005-09-15 Absorber Ab Endothelial progenitor cells and methods of use thereof
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
EP1901761A4 (en) * 2005-06-24 2009-08-12 Cadila Healthcare Ltd THROMBOSPONDIN-1 GENERATING PEPTIDES AND TREATMENT PROCESS
RU2295963C1 (ru) * 2005-10-18 2007-03-27 Закрытое акционерное общество Научно-производственное предприятие "Тринита" Способ получения иммуностимулятора
WO2007142769A1 (en) * 2006-05-03 2007-12-13 Therakos, Inc. Methods for treating diseases involving stress-related diseases and conditions
BRPI0919804A8 (pt) * 2008-10-05 2016-10-11 Friedlander Hymie Métodos e composição para o tratamento de problemas dermatológicos e/ou condições de cabelo
EP2201954A1 (en) * 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation

Also Published As

Publication number Publication date
US11235003B2 (en) 2022-02-01
ES2429518T3 (es) 2013-11-15
CN102256608A (zh) 2011-11-23
EP2379085A1 (en) 2011-10-26
CA2746862C (en) 2017-08-29
AU2009336668B2 (en) 2014-05-08
RU2011129676A (ru) 2013-01-27
CA2746862A1 (en) 2010-07-15
BRPI0922174A2 (pt) 2015-12-29
EP2198873A1 (en) 2010-06-23
AU2009336668A1 (en) 2011-07-07
EP2379085B1 (en) 2013-07-10
RU2533253C2 (ru) 2014-11-20
JP2012512842A (ja) 2012-06-07
NZ593364A (en) 2012-11-30
US20120045418A1 (en) 2012-02-23
WO2010079086A1 (en) 2010-07-15
ZA201104349B (en) 2012-02-29
CN102256608B (zh) 2013-12-04
JP5869343B2 (ja) 2016-02-24

Similar Documents

Publication Publication Date Title
DK2344682T3 (da) Elektrode for elektrolysecelle
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
FI20106121A7 (fi) Soluviljelymateriaali
DK3495498T3 (da) Genekspressionsanalyse i enkeltceller
DK2574677T3 (da) Fremgangsmåder til celledyrkning
ZA201104349B (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
DE102008055028A8 (de) Solarzelle
BR112012014158A2 (pt) "célula eletroquímica"
DK2448963T3 (da) T-celle receptorer
BRPI1010035A2 (pt) Células deficientes em fucosilação
EP2501466A4 (en) POROUS MATERIALS
ITVR20080024A1 (it) Struttura di tramoggia
DK2252395T3 (da) Afsvovlingsmaterialer
DE602008000048D1 (de) Brennstoffzelle
SMP201100036B (it) Reattore elettrochimico
PL2379086T3 (pl) Preparat farmeceutyczny
EP2272955A4 (en) TDP-43 MEMORY CELL MODEL
FI20086072A0 (fi) Kennolevy
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0921313A2 (pt) composição farmaucêutica
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
BRPI0814572A2 (pt) Célula de lítio
BRPI0923585A2 (pt) célula de pesagem
EP2362470A4 (en) FUEL CELL
EP2309553A4 (en) INTERCONNECTS